Industry Sessions
24 May 2023
13:15 – 14:15, Room 13A
Industry Satellite Symposia
From prevention to acute stroke: advances across stroke pathways
Chairperson: Hanno Herrmann
13:15 – 13:25, Lowering the global burden of stroke” – Siemens Healthineers’ strategy to optimize stroke treatment and prevent recurrences, Hanno Herrmann
13:25 – 13:35, From prevention to acute stroke: current challenges, Pieter Jan van Doormaal
13:35 – 13:50, NAEOTOM Alpha: increased diagnostic performances with photon-counting CT technology, Pieter Jan van Doormaal
13:50 – 14:05, How ARTIS icono helps in treatment and prevention of hemmorhagic stroke, Markus Holtmannspötter
14:05 – 14:15, Q&A, Hanno Herrmann, Pieter Jan van Doormaal, Markus Holtmannspötter
Organised by Siemens Healthineers
13:15 – 14:15, Room 13B
Industry Satellite Symposia
Evidence-based therapies for all stroke patients – advances and guideline recommendations
Chairperson: Ales Tomek
13:15 – 13:30, Introduction, Ales Tomek
13:30 – 13:50, Get with the guidelines in post stroke motor recovery, Steven Zeiler
13:50 – 14:15, Effective Cerebroprotection in the stroke reperfusion era – why we need it?, Jacek Staszewski
Organised by EVER Pharma
13:15 – 14:15, Room 4
Industry Satellite Symposia
Stroke Care Optimization Driven by Real World Evidence
Chairperson: Raul Nogueira
13:15 – 13:30, The Andalucian Stroke Network Experience, Joan Montaner
13:30 – 13:45, Brainomix in the Real World: Reflections & Learning on e-Stroke, Kiruba Nagaratnam
13:45 – 14:00, Health Economic Benefits of Mechanical Thrombectomy, Manu Moreu
14:00 – 14:15, Building a Regional Thrombectomy Network with e-Stroke, Alex Szolics
Organised by Brainomix
25 May 2023
13:15 – 14:45, Room 13A
Industry Satellite Symposia
Population Awareness – The Final Frontier
Chairperson: Simona Sacco
13:15 – 13:30, Speaking To Stroke Patients: Understanding What Our Patients Do Before They Arrive At The Hospital, Hong Chuan Loh
13:30 – 13:50, Fast Heroes – On A Grand Mission To Save Our Grandparents, Sheila Martins
13:50 – 14:10, 250,000 Families Say It Works!, Jan van der Merwe
14:10 – 14:30, How Your Hospital Can Get Involved, Sandra Martins, Catarina Maria Frias Rodrigues
14:10 – 14:30, World Health Organization: Implementing Fast Heroes In Kyrgysztan, Aliina Altymysheva
Organised by Angels Initiative
13:15 – 14:15, Room 13B
Industry Satellite Symposia
Customized Stroke Management: Embracing Personalized Care and Latest Technologies
Chairperson: Luca Callegari
13:15 – 13:35, AF Screening in Cryptogenic Stroke – monitoring strategies and patient selection, Danilo Toni
13:35 – 13:55, Early procedural experience with the Solitaire 3mm MeVO device, Markus Möhlenbruch
13:55 – 14:15, Rationale behind MeVO treatments, Urs Fischer
Organised by Medtronic
13:15 – 14:45, Room 5
Industry Satellite Symposia
Real-World Data and the Management of ICH in Anticoagulated Patients
Chairperson: W. Brian Gibler
13:15 – 13:20, Welcome, Introductions, and Symposium Pre-Test, W. Brian Gibler
13:20 – 13:28, Repletion or Reversal? Optimizing Specific Therapy for Direct Oral Anticoagulant (DOAC)-Related Life-Threatening Bleeding Using Real-World Experience, Natalie Kreitzer
13:28 – 13:35, Case Presentation: Management of a Patient With Vitamin K Antagonist-Associated Intracranial Hemorrhage (ICH), Natalie Kreitzer13:35 – 13:45, Roundtable Discussion: Repletion Management for Vitamin K Antagonist Anticoagulation, All: W. Brian Gibler, Natalie Kreitzer, David Seiffge, Adrian Parry-Jones
13:45 – 13:53, Reversal of Factor Xa Inhibitor ICH: ANNEXA-4, ANNEXA-I and Real-World Evidence, David Seiffge
13:53 – 14:00, Case Presentation: Management of a Patient With Factor Xa-Associated ICH Using Specific Reversal Therapy, David Seiffge
14:00 – 14:10, Roundtable Discussion: Specific Reversal Therapy for Factor Xa and Factor IIa Inhibitor-Associated ICH Life-Threatening Bleeding, All: W. Brian Gibler, Natalie Kreitzer, David Seiffge, Adrian Parry-Jones
14:10 – 14:18, Development of a Critical Care Pathway for Patients With ICH Using Specific Reversal Agents for Anticoagulated Patients With ICH, Adrian Parry-Jones
14:18 – 14:25, Case Presentation: Management of ICH in the Anticoagulated Patient Using Specific Reversal Therapy – Importance of Timing, Adrian Parry-Jones
14:45, Roundtable Discussion, Post-Test, and Audience Q & A – Reinforcement of Principles and Overcoming Treatment Barriers, All: W. Brian Gibler, Natalie Kreitzer, David Seiffge, Adrian Parry-Jones
Organised by AstraZeneca
13:15 – 14:45, Room 2
Industry Satellite Symposia
Factor XI(a) Inhibition: A New Approach in Secondary Stroke Prevention and Patient Protection?
Chairperson: Valeria Caso
13:15 – 13:20, Welcome and Introductions, Valeria Caso
13:20 – 13:30, Epidemiology of Stroke and Burden of Disease, Valeria Caso
13:30 – 13:40, Current Approaches in Antithrombotic Therapy, Martin Dichgans
13:40 – 13:50, Unmet Medical Need, Mike Sharma
13:50 – 14:05, Evolution of FXIa as a Target and Mechanism of Action, John Eikelboom
14:05 – 14:20, Existing Clinical Studies in FXIa Inhibition for Secondary Stroke Prevention, Ashkan Shoamanesh
14:20 – 14:40, Panel Discussion and Q&A, All: Valeria Caso, Martin Dichgans, Mike Sharma, John Eikelboom, Ashkan Shoamanesh
14:40 – 14:45 Closing Remarks, Mike Sharma
Organised by Bayer
14:15 – 14:45, Room 11
Industry Meet The Expert Session
Anticoagulation for AF patients with stroke: an update from guidelines and clinical practice
Chairperson: Rónán Collins
14:15 – 14:17, Welcome and introduction, Rónán Collins
14:17 – 14:25, Spotlight on latest guideline recommendations: a perspective on anticoagulation after stroke, Rónán Collins
14:25 – 14:33, Insights from real-world evidence: anticoagulation for AF stroke patients in clinical routine, Paolo Profice
14:33 – 14:43, Q&A session and panel discussion, All: Rónán Collins, Paolo Profice
14:43 – 14:45, Summary and conclusion, Rónán Collins
Organised by Daiichi Sankyo
14:15 – 14:45, Room 4
Industry Meet The Expert Session
A case-based debate: which of your patients might benefit from left atrial appendage occlusion?
Chairperson: Peter Rothwell
Debate session, Panel: Hans Christoph Diener, Marta Rubiera del Fueyo
Moderator: Peter Rothwell
Organised by Abbott